Breaking Corporate Events, Analysed in Real Time

Kwality Pharmaceuticals Targets ₹700 Crore Revenue in FY27 Following Guidance Revision

Kwality Pharmaceuticals has upwardly revised its FY27 revenue guidance to over ₹700 crore, reflecting a 40 percent year-on-year growth target. The company is strategically positioning itself to double its revenue to ₹1,500 crore by FY30, driven by aggressive international registrations and the commissioning of new manufacturing facilities.

Kwality Pharmaceuticals Q1FY27: Revenue Surges 45% as FY27 Guidance Raised to ₹700 Cr+

Kwality Pharmaceuticals Ltd reported a strong start to FY27 with revenue growing 45.7% year-on-year to ₹162.4 Cr. Following robust execution in regulated markets, management has upwardly revised its FY27 revenue guidance to over ₹700 Cr, citing increased visibility and a stronger product mix.